前苏联专利SU1757464A3 Method for preparation of amino derivatives of benzoxazolone

专利PDF首页>>前苏联专利

专利附录

专利说明

权利要求

类似技术

同族专利

引用文献

法律状态

优先权

专利摘要:
Compounds of the formula where Y is alkyl, aryl or heterocyclic, n is 1-7, R is hydrogen, alkyl, aralkyl or carboxymethyl, R₁ is hydrogen, halo, alkyl, alkoxy or trifluoromethyl, R₂ is hydrogen, alkyl or alkanoyl and X is C=O, CH2, NH, O or S as antiallergy and antiinflammatory agents.
公开号:SU1757464A3
申请号:SU874202723
申请日:1987-06-08
公开日:1992-08-23
发明作者:Китаура Иесихико；Ито Фумитака；Уильям Стевенс Родни；Асаи Новуко
申请人:Пфайзер Корпорейшн, Ра (Фирма)；
IPC主号:

专利说明:

This invention relates to a process for the preparation of new heterocyclic compounds, namely new benzoxazolone derivatives, which are inhibitors of both cyclooxygenase and lipoxygenase and can be used in the treatment or reduction of allergic or inflammatory reactions in mammals, including humans.
The purpose of the invention is the synthesis of new compounds in the benzoxazolone range, which surpasses in structural activity a structural analogue possessing the same type of activity.
Example 1. 7-Chloro-6-phenylimino-2-benzoxazolone, compound of formula
X
(snly {NEOo
"T N-R,
Y6, 10 g of 6-amino-7-chloro-2-benzoxazolone was combined with 4.00 ml of benzaldehyde and the mixture was kept at 100 ° C for 1 h, then diluted with 60 ml of ethanol and concentrated under reduced pressure to obtain an oil-like residue. This residue was crystallized from ethanol to yield the title compound as a brown powder (NMR spectrogram {DMSO-de, delta): 7.13 (m, 2H). 7.55 (m. 3N), 7.97 (m. 2H). 8.61 (s. 1H).
The following compounds were obtained by the reaction of the corresponding 2-benzoxazolone with the necessary aldehydes according to the same procedure: 5-ethyl-6- (3-tolyl) - imino-2-benzoxazolone (NMR spectrogram (DMSO-C 6. delta ): 1.12 (t., ZN, 7 Hz), 2.39 (s. ZN). 2.80 (r., 2H. 7 Hz), 6.97 (s., 1H), 7.21 ( s. 1H), 7.35 (t., 1H, 7 Hz (. 7.41 (t. 1H,).
VI SP VI
-N
gk

WITH
7.73 (d, 1H, 8 Hz), 7.74 (s, 1H). 8.55 (s, 1H) and 6- (pyridin-3-yl) -imino-2-benzoxazolone (NMR spectrogram (DMSO-de, delta): 7.13 (d.O 1H, 8 Hz), 7, 19 (d., 1H, 8 Hz), 7.41 (s., 1H), 7.55 (dd, 1I, 5Hz, 8 Hz), 8.30 (d., 1H, 8 Hz), 8 , 70 (d., 1H, 5 Hz), 8.77 (s., 1H), 9.05 (s., 1H).
Example 2. 7-Chloro-6-benzyl-emin-2-benzoxazolone, compound of formula
P
770 mg of compound (II) was dissolved in 10 ml of methanol. 100 mg of sodium borohydride was added to the solution and stirred at room temperature. The mixture was then diluted with 5% sodium bicarbonate solution and the product was extracted with dichloromethane. The dichloromethane layer was separated, washed with brine, dried over anhydrous sodium sulfate, and evaporated to give a crude product. As a result of recrystallization, purified compound (I) was obtained.
Melting point 199-201 ° C.
And "- spectrogram (liquid paraffin): 3410, 3270, 1800, 1735.
NMR spectrogram (270 MHz): 4.38 (d, 1H, 5.83 Hz), 6.00-6.04 (n. 1H), 6.29 (d, 1H, 8.79 Hz ), 6.77 (d, 1H, 8.06 Hz), 7.20-7.55 (m, 5H), 11.34 (broad s., 1H).
Reduction of 5-ethyl-6- (3-tolyl) -imino-2-benzoxazolone and b- (pyridin-3-yl) -imino-2-benzoxazolone in the presence of sodium borohydride & basically, in accordance with the above procedure, it was possible to obtain the following compounds: 5-ethmyl-b- (3-tolylmethyl) -amino-2-benzox zo with a melting point of 161-163 ° C and 6- {pyridmn-3-ylmethyl) -amino -2-benzoxazolone with a melting point of 184-186 ° C.
The compounds listed in Table. 1, obtained according to the method of examples 1 and 2.
According to examples 1 and 2, the compounds shown in Table 1 were obtained. 2 and 3.
The compounds of the present invention are inhibitors of both cyclo-oxenase (CO) and lipoxyherase (III) enzymes. It is thanks to this mechanism that they have not only anti-inflammatory, but also anti-allergic effects. This effect has been studied in laboratory conditions with respect to the inhibition of CO and LO enzymes. To compare previously known compounds with the proposed compounds in relation to the inhibitory effect on these
enzymes, using a cell culture test method using rat abdominal cells (RPC). Typical results obtained with
using various compounds of the present invention, compared with 5-chloro-6-benzoyl-2-benzoxazolin.
In a comparative compound, the inhibitory ICso concentration is 1.3 M
against CO-enzyme and a value in excess of 30 M against the LO-enzyme. In contrast, the proposed compounds are characterized by ICso (CO) in the range of 3-30 and ICso (LO) in the range of 0.1-10, respectively. Act
Compounds in this case are expressed as inhibitory molar concentration (ICso, M), which is able to inhibit the action of each enzyme by 50% of its action under normal conditions. In spite of
that the comparative compounds exhibit a slightly stronger CO inhibitory effect than the compounds of formula (I), they actually have no LO inhibitory effect, therefore
suggest that they may not be effective against antiallergic indications. Due to its inhibitory effect of CO, the proposed compounds are capable of performing the functions of anti-inflammatory agents in the same way as the effect of the comparative compound. Nevertheless, it is possible that they have less gastrointestinal adverse effects than this comparative compound, but not to the same extent show an inhibitory effect. It is generally assumed that they are equally characterized as anti-inflammatory and anti-allergic agents.
In terms of toxicity, the proposed compounds can be classified as compounds of moderate toxicity.
CO inhibition values (in vitro
cyclooxygenase) and LO (lipoxygenase) - ICBO, concentrations (ft M) for 50% inhibition are given,

权利要求:
Claims (1)
[1]
The invention method for producing amino derivatives
benzoxazolone General formula
55
Y- (CH2) nN
N-R where RI is hydrogen, methoxy, methyl, fluorine;
R2 is hydrogen, Ci-Cz-alkyl;
X is oxygen;
n 1-7; characterized in that the compound
Y - methyl, styryl, phenylamino. fenok- general formula si or phenyl, X
Y- (CHzVtCH NHpC 0
1 R2 where Ri, RZ, Y and n have the indicated meanings, is subjected to reduction with borohydride
NETRIA-T.5 „C,,
ten
- V
N
J 82B ° 2 Ј JSS IS§2i i
Y- (CH2) nN O
Ki N N
/ U

类似技术:

公开号 | 公开日 | 专利标题

SU1757464A3|1992-08-23|Method for preparation of amino derivatives of benzoxazolone

EP1560826B1|2006-04-12|Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same

US5990311A|1999-11-23|Process for preparation of pyrimidine derivatives

FI72719C|1987-07-10|SYNTESFOERFARANDE FOER PIROXIKAM SAMT MELLANPRODUKT.

JP4501015B2|2010-07-14|Method for producing aminopyrimidine compound

US5498711A|1996-03-12|Synthesis of 4,10-dinitro-2,6,8,12-tetraoxa-4,10-diazatetracyclo[5.5.0.05,903,11]dodecane

HUT64759A|1994-02-28|Method for producing tetrazolyl-|-pyridinyl-pyridazines

EP0348257A2|1989-12-27|aryl-diazole derivatives, process for their preparation and their therapeutical use

JP3712619B2|2005-11-02|Catechol hydrazone derivative, production method and pharmaceutical composition containing the same

SU1436873A3|1988-11-07|Method of producing derivatives of 1,2,4-triazolecarbamate or acid-additive salts thereof

US4894389A|1990-01-16|Novel aminoalkyl-substituted heterocyclic sulfur compounds

US4940712A|1990-07-10|Derivatives of hydroxyprimidines as leukotriene synthesis inhibitors

US4157340A|1979-06-05|N,N'-[Bis|]cystamine derivatives

SU936811A3|1982-06-15|Process for producing pyridazinylhydrazones or their acid additive salts

CA1244435A|1988-11-08|Pyrazolo¬1,5-a|pyridine derivatives andcompositions containing them

CA1336516C|1995-08-01|Acyl derivatives of 2-amino-4-substituted-5-hydroxy pyrimidines

CA1310642C|1992-11-24|2-amino-5-hydroxy-4-pyrimidones

EP1065202B1|2005-08-03|6-|-4-pyrimidones and process for producing the same

US3320272A|1967-05-16|Process for preparing z-alkoxycyclo-heptimidazole derivatives

US5091403A|1992-02-25|Sulfinyl imidazole derivatives and antiulcer agents containing the same

US4528372A|1985-07-09|N-Phthalidyl-5-fluorouracils

US4650893A|1987-03-17|Bis-imido carbonate sulphones

KR970001476B1|1997-02-06|New benzimidazole derivatives with amide groups

JP4110633B2|2008-07-02|3-Amino-4-fluoro-2-unsaturated carboxylic acid ester and process for producing the same

KR810000481B1|1981-05-20|Process for the preparation of substituted n-| 1-3-aminopropane-2-ol

同族专利:

公开号 | 公开日

DK288287A|1987-12-10|

DD265141A5|1989-02-22|

PL266132A1|1988-06-23|

YU104987A|1988-08-31|

FI872555A0|1987-06-08|

EP0249407B1|1991-01-30|

AU586337B2|1989-07-06|

ES2031892T3|1996-07-16|

HUT48209A|1989-05-29|

NO872382L|1987-12-10|

NO168246B|1991-10-21|

AU7387887A|1987-12-10|

ZA874046B|1989-01-25|

AT60596T|1991-02-15|

HU198451B|1989-10-30|

JPS63107958A|1988-05-12|

CN1015334B|1992-01-29|

KR900000552B1|1990-01-31|

NO168246C|1992-01-29|

PT85035A|1987-07-01|

JPH0623199B2|1994-03-30|

FI87924B|1992-11-30|

DK288287D0|1987-06-04|

GR3001584T3|1992-11-23|

KR880000413A|1988-03-25|

FI87924C|1993-03-10|

NO872382D0|1987-06-05|

CA1305151C|1992-07-14|

IE60015B1|1994-05-18|

CN87104099A|1988-02-10|

FI872555A|1987-12-10|

IE871505L|1987-12-09|

EP0249407A2|1987-12-16|

YU45423B|1992-05-28|

PT85035B|1990-03-08|

EP0249407A3|1988-10-19|

PL150631B1|1990-06-30|

DE3767778D1|1991-03-07|

引用文献:

公开号 | 申请日 | 公开日 | 申请人 | 专利标题

RU2629936C2|2012-05-21|2017-09-05|Др. Аугуст Вольфф Гмбх Унд Ко. Кг Арцнаймиттель|New 1,3-benzoxazol-2-ones and their application as pharmaceutical drugs and cosmetics|JPS5663972A|1979-10-30|1981-05-30|Tetsujirou Masuko|Preparation of novel benzothiazolone derivative containing novel heterocyclic quaternary salt|

DE3017977A1|1980-05-10|1981-11-19|Dr. Karl Thomae Gmbh, 7950 Biberach|NEW SUBSTITUTED 2 -ZENZOTHIAZOLONE|

DE3042481A1|1980-11-11|1982-06-16|A. Nattermann & Cie GmbH, 5000 Köln| - -ALKANIC ACID DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM|

GB8325370D0|1983-09-22|1983-10-26|Fujisawa Pharmaceutical Co|Benzoxazoline and benzothiazoline derivatives|

US4569942A|1984-05-04|1986-02-11|Pfizer Inc.|N,3-Disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents|

US4690943A|1984-09-19|1987-09-01|Pfizer Inc.|Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds|US4720297A|1985-09-27|1988-01-19|Sumitomo Chemical Company, Limited|Benzothiazolones, and their production and use as herbicides|

IL93473D0|1989-02-28|1990-11-29|Pfizer|Antiinflammatory benzoxazolones|

AU6966696A|1995-10-05|1997-04-28|Warner-Lambert Company|Method for treating and preventing inflammation and atherosclerosis|

US6001866A|1995-10-05|1999-12-14|Warner-Lambert Company|Method for treating and preventing inflammation and atherosclerosis|

US5972980A|1995-10-05|1999-10-26|Warner-Lambert Company|Method for treating and preventing inflammation and atherosclerosis|

US7186745B2|2001-03-06|2007-03-06|Astrazeneca Ab|Indolone derivatives having vascular damaging activity|

DE10210779A1|2002-03-12|2003-10-09|Merck Patent Gmbh|Cyclic amides|

TW200508197A|2003-03-31|2005-03-01|Ucb Sa|Indolone-acetamide derivatives, processes for preparing them and their uses|

US7270805B1|2006-03-30|2007-09-18|Conopco, Inc.|Skin lightening agents, compositions and methods|

WO2010090680A1|2008-12-15|2010-08-12|Wyeth Llc|Substituted oxindole cb2 agonists|

WO2013024358A2|2011-08-18|2013-02-21|Dr. Reddy's Laboratories Ltd.|Substituted heterocyclic amine compounds as cholestryl ester-transfer proteininhibitors|

EP3932395A1|2020-07-03|2022-01-05|Dr. August Wolff GmbH & Co. KG Arzneimittel|Stable emulsion containing an active pharmaceutical ingredient based onndodecanamide,production and use|

法律状态:

优先权:

申请号 | 申请日 | 专利标题

JP13347086|1986-06-09|

[返回顶部]